Cellvie is a startup based in the United States, 2 tracked investors.
Cellvie is a company headquartered in the United States. Brouky records 2 investors associated with the company.
Cellvie is a Harvard spin-off developing Therapeutic Mitochondria Transfer (TMT) to deliver functional mitochondria as a therapeutic modality, targeting ischemia–reperfusion injury and other mitochondrial-linked degenerative or age-related conditions.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.